ICCC · CIK 0000811641 · FY2025 live · 2025-12-31
IMMUCELL CORP /DE/
View as
Model
Classic Z
FY2025
1.69
Zone
Distress
Prior
—
Market DD
—
1y PD
—
1.69
Z″ 2.93
Score 1.69 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.301.2 × = 0.37X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−0.361.4 × = −0.50X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
0.043.3 × = 0.13X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
1.750.6 × = 1.05X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.651 × = 0.65
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
IMMUCELL CORP /DE/ is on classic Z at 1.69 (distress) for FY2025, from an SEC 10-K. Book equity / liabilities is the line that sets the print; sales / assets is the runner-up. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 74th percentile in Healthcare.
- ICUIDistressICU MEDICAL INC/DE1.69
- DMACDistressDiaMedica Therapeutics Inc.1.69
- BEAMDistressBeam Therapeutics Inc.1.70
- CNTNDistressCanton Strategic Holdings, Inc.1.68
- TFXDistressTELEFLEX INC1.67
- COYADistressCoya Therapeutics, Inc.1.72
- BCYCDistressBICYCLE THERAPEUTICS PLC1.66
- MRKDistressMerck & Co., Inc.1.73
KPI widgets
Current assets
$17M
Total assets
$43M
Current liabilities
$4M
Total liabilities
$15M
Working capital
$13M
Retained earnings
−$15M
EBIT
$2M
Total sales
$28M
Book equity
$27M
Accession 0001437749-26-010339. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 12 Sept 2026.